FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Wein

Research Profile

Disorders

Prostatic Neoplasms

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Ariana Smith; Alan Wein
Current pharmacotherapy of nocturia.
Olivia S Jung; David Lee; Michael Mehler; Mark Pauly; Anand Shah; Neha Vapiwala; Alan Wein; John Christodouleas; Curtiland Deville; THOMAS GUZZO; Genevieve Hollis; Justin E Bekelman
Out-of-pocket expenses and treatment choice for men with prostate cancer.
Philip Hanno; Alex Lin; Jørgen Nordling; Leroy Nyberg; Arndt van Ophoven; Tomohiro Ueda; Alan Wein
Bladder Pain Syndrome Committee of the International Consultation on Incontinence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Wein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ariana Smith; Alan Wein
Current pharmacotherapy of nocturia.
Expert opinion on pharmacotherapy 2013;14(7):885-94.
2012: Olivia S Jung; David Lee; Michael Mehler; Mark Pauly; Anand Shah; Neha Vapiwala; Alan Wein; John Christodouleas; Curtiland Deville; THOMAS GUZZO; Genevieve Hollis; Justin E Bekelman
Out-of-pocket expenses and treatment choice for men with prostate cancer.
Urology 2012;80(6):1252-7.
2010: Philip Hanno; Alex Lin; Jørgen Nordling; Leroy Nyberg; Arndt van Ophoven; Tomohiro Ueda; Alan Wein
Bladder Pain Syndrome Committee of the International Consultation on Incontinence.
Neurourology and urodynamics 2010;29(1):191-8.
2007: Elaine Spangler; Charnita Zeigler-Johnson; M Coomes; S Bruce Malkowicz; Alan Wein; Timothy R Rebbeck
Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men.
The Journal of urology 2007;178(5):1939-44; discussion 1945.
2006: Edward F Labelle; Stephen A Zderic; Daniel P Delaney; Joseph A Hypolite; Alan Wein; Samuel Chacko
Lipid signaling changes in smooth muscle remodeling associated with partial urinary bladder outlet obstruction.
Neurourology and urodynamics 2006;25(2):179-84.
2005: Hanna Rennert; Charnita Zeigler-Johnson; Kathakali Addya; Matthew J Finley; Amy H Walker; Elaine Spangler; Debra G B Leonard; Alan Wein; S Bruce Malkowicz; Timothy R Rebbeck
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):949-57.
2004: Samuel Chacko; Shaohua Chang; Joseph A Hypolite; Michael E DiSanto; Alan Wein
Alteration of contractile and regulatory proteins following partial bladder outlet obstruction.
Scandinavian journal of urology and nephrology. Supplementum 2004;(215):26-36.
2002: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Kerri Cote; Marian Loffredo; Delray Schultz; Ming-Hui Chen; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.
Cancer 2002;95(2):281-6.
2002: Marshal E Lieberfarb; Delray Schultz; Richard Whittington; Bruce Malkowicz; John E Tomaszewski; Michael Weinstein; Alan Wein; Jerome P Richie; Anthony V D'Amico
Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy.
International journal of radiation oncology, biology, physics 2002;53(4):898-903.
2002: Anthony V D'Amico; Ming-Hui Chen; S Bruce Malkowicz; Richard Whittington; Andrew A Renshaw; John E Tomaszewski; Yelina Samofalov; Alan Wein; Jerome P Richie
Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less.
The Journal of urology 2002;167(5):2025-30; discussion 2030-1.
2001: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; M Weinstein; John E Tomaszewski; Delray Schultz; M Rhude; S Rocha; Alan Wein; Jerome P Richie
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era.
The Journal of urology 2001;166(6):2185-8.
2001: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Andrew A Renshaw; John E Tomaszewski; C Bentley; Delray Schultz; S Rocha; Alan Wein; Jerome P Richie
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening.
Urology 2001;58(3):406-10.
2000: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Y H Wu; Ming-Hui Chen; Mark Hurwitz; Philip W Kantoff; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(18):3240-6.
2000: Anthony V D'Amico; Richard Whittington; B Malkowicz; Mitchell D Schnall; Delray Schultz; Kerri Cote; John E Tomaszewski; Alan Wein
Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer.
The Journal of urology 2000;164(3 Pt 1):759-63.
2000: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; J Fondurulia; M H Chen; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1164-72.
2000: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Barbara Silver; L Henry; Mark Hurwitz; Irving Kaplan; Clair Beard; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer.
Molecular urology 2000;4(3):171-5;discussion 177.
1999: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Andrew A Renshaw; John E Tomaszewski; Jerome P Richie; Alan Wein
Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage.
International journal of radiation oncology, biology, physics 1999;45(5):1227-33.
1999: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; J Fondurulia; M H Chen; Irving Kaplan; Clair Beard; John E Tomaszewski; Andrew A Renshaw; Alan Wein; C Norman Coleman
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):168-72.
1998: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; J Fondurulia; M H Chen; John E Tomaszewski; Alan Wein
The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer.
The Journal of urology 1998;160(6 Pt 1):2096-101.
1998: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; John E Tomaszewski; Alan Wein
A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer.
Urology 1998;52(4):631-6.
1998: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; K Blank; G A Broderick; John E Tomaszewski; Andrew A Renshaw; Irving Kaplan; Clair Beard; Alan Wein
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
JAMA : the journal of the American Medical Association 1998;280(11):969-74.
1998: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Irving Kaplan; Clair Beard; John E Tomaszewski; Andrew A Renshaw; K R Loughlin; Jerome P Richie; Alan Wein
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3094-100.
1998: Anthony V D'Amico; A Desjardin; A Chung; Ming-Hui Chen; Delray Schultz; Richard Whittington; S Bruce Malkowicz; Alan Wein; John E Tomaszewski; Andrew A Renshaw; Kevin R Loughlin; Jerome P Richie
Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy.
Cancer 1998;82(10):1887-96.
1998: Anthony V D'Amico; Mitchell D Schnall; Richard Whittington; S Bruce Malkowicz; Delray Schultz; John E Tomaszewski; Alan Wein
Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease.
Urology 1998;51(3):449-54.
1998: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schultz; S Bruce Malkowicz; Alan Wein; John E Tomaszewski; C Norman Coleman
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
Cancer 1998;82(2):334-41.
1998: David J Vaughn; S Bruce Malkowicz; Barbara H Zoltick; Rosemarie Mick; Parvati Ramchandani; Christopher Holroyde; B Armstead; Kevin Fox; Alan Wein
Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):255-60.
1997: Anthony V D'Amico; Richard Whittington; Delray Schultz; S Bruce Malkowicz; John E Tomaszewski; Alan Wein
Outcome based staging for clinically localized adenocarcinoma of the prostate.
The Journal of urology 1997;158(4):1422-6.
1997: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schultz; S Bruce Malkowicz; John E Tomaszewski; Alan Wein; C Norman Coleman
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
International journal of radiation oncology, biology, physics 1997;39(2):335-40.
1997: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; John E Tomaszewski; Alan Wein
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1465-9.
1997: Anthony V D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; MR Jiroutek; S Bruce Malkowicz; Alan Wein; C Norman Coleman
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.
International journal of radiation oncology, biology, physics 1997;37(5):1053-8.
1997: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Mitchell D Schnall; John E Tomaszewski; Alan Wein
Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure.
Urology 1997;49(3A Suppl):23-30.
1997: David J Vaughn; S Bruce Malkowicz; Barbara H Zoltick; Parvati Ramchandani; B Tonkonow; B Armstead; Alan Wein
Phase I trial of paclitaxel/carboplatin in advanced carcinoma of the urothelium.
Seminars in oncology 1997;24(1 Suppl 2):S2-47-S2-50.
1996: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Mitchell D Schnall; John E Tomaszewski; Alan Wein
Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients.
The cancer journal from Scientific American 1996;2(6):343-50.
1996: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Delray Schultz; Mitchell D Schnall; John E Tomaszewski; Alan Wein
Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1770-7.
1996: Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; K Loughlin; Delray Schultz; Mitchell D Schnall; Clare M C Tempany; John E Tomaszewski; Andrew A Renshaw; Alan Wein
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy.
Urology 1996;47(4):538-47.